{"schema_version":"secwatch.filing_event.v1","accession":"0001360604-23-000084","form_type":"8-K","ticker":"HR","cik":"0001360604","company_name":"Healthcare Realty Trust Inc","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.701320+00:00","generated_at":"2026-06-12T01:16:00.277434+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Healthcare Realty Trust Q2 net loss $82.8M, normalized FFO $0.39/share","bullets":["Net loss of $82.8M ($0.22 diluted EPS); Normalized FFO of $149.8M ($0.39 diluted).","Merger Combined Same Store cash NOI up 2.1% YoY; occupancy 89.0% (up 20 bps).","Weighted average MOB cash leasing spreads of 3.0% on 598K sq ft renewed; tenant retention 80.5%.","Expects >$300M property sale proceeds by year-end; net debt/EBITDA 6.6x.","Dividend of $0.31/share declared, payable Aug 30, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001360604-23-000084","json":"https://secwatch.observer/filing/0001360604-23-000084.json","markdown":"https://secwatch.observer/filing/0001360604-23-000084.md","text":"https://secwatch.observer/filing/0001360604-23-000084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000084/0001360604-23-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000084/hr-20230808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T01:16:00.277434+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e810f516dd92f6f31ce18c74ce1fb6f3bac73e5d","claim":"Healthcare Realty Trust Inc reported second quarter ended June 30, 2023 results: net income net loss attributable to common stockholders of $82.8 million, EPS $0.22 per diluted common share.","evidence_excerpt":"The Company reported net loss attributable to common stockholders of $82.8 million, or $0.22 per diluted common share, for the quarter ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000084/0001360604-23-000084-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Net income","value":"net loss attributable to common stockholders of $82.8 million"},{"label":"EPS","value":"$0.22 per diluted common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}